🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: chemotherapy plus cemiplimab

Found 57 matching trials

A Clinical Study to Assess the Efficacy of Adjuvant Immunotherapy With Cemiplimab in Patients With Surgically Removed Non-small Cell Lung Cancer Who Have Not Received Prior Chemotherapy

PHASE3

ARCH is a randomised, stratified, multicentre, phase III trial. Protocol tr...

Status

Recruiting

Location

Wien AKH

Start Date

2026-01-12

Trial ID

NCT06931717

Treatments Being Tested

Cemiplimab

A PHASE II, RANDOMIZED STUDY TO ASSESS MAINTENANCE THERAPY WITH CEMIPLIMAB VERSUS BEST SUPPORTIVE CARE AFTER 1ST LINE PLATINUM-BASED CHEMOTHERAPY IN ADVANCED/RECURRENT PENILE CANCER

PHASE2

This is a phase II, randomized study which will enroll participants given 4...

Status

Not Yet Recruiting

Location

Hospital Israelita Albert Einstein

Start Date

2025-12

Trial ID

NCT07101822

Treatments Being Tested

Cemiplimab

Evaluation of Cemiplimab in Combination With Platinum-Doublet Chemotherapy in First-Line (1L) Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) in Adult United States (US) Patients

N/A

This multi-year cohort study will assess the real-world safety and effectiv...

Status

Active Not Recruiting

Location

Regeneron Research Facility

Start Date

2024-02-21

Trial ID

NCT06269133

Treatments Being Tested

REGN2810 Platinum-doublet chemotherapy

Photoimmunotherapy With ASP-1929 and Cemiplimab for the Treatment of Refractory, Inoperable, and Metastatic Stage IIIB-IV Non-small Cell Lung Cancer

PHASE2

This phase II trial tests how well photoimmunotherapy (PIT) with ASP-1929 i...

Status

Not Yet Recruiting

Location

Roswell Park Cancer Institute

Start Date

2026-08-15

Trial ID

NCT06943664

Treatments Being Tested

Biospecimen Collection Cemiplimab Cetuximab Sarotalocan Sodium Computed Tomography Electronic Health Record Review Endobronchial Ultrasound Bronchoscopy Magnetic Resonance Imaging Photoimmunotherapy Photoimmunotherapy Positron Emission Tomography Robotic Bronchoscopy Video-Assisted Thoracic Surgery

A PHASE II, RANDOMIZED TRIAL TO ASSESS MAINTENANCE THERAPY WITH CEMIPLIMAB VERSUS BEST SUPPORTIVE CARE AFTER 1ST LINE PLATINUM-BASED CHEMOTHERAPY IN ADVANCED/RECURRENT VULVAR CANCER

PHASE2

This is a phase II, randomized study that will include 42 participants who ...

Status

Not Yet Recruiting

Location

Hospital Israelita Albert Einstein

Start Date

2025-11-01

Trial ID

NCT07101848

Treatments Being Tested

Cemiplimab

Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer

PHASE2

This phase II trial tests the addition of chemotherapy, with carboplatin an...

Status

Recruiting

Location

Banner University Medical Center - Tucson

Start Date

2026-04-24

Trial ID

NCT07195734

Treatments Being Tested

Biospecimen Collection Carboplatin Cemiplimab Cisplatin Computed Tomography Paclitaxel Positron Emission Tomography Radiation Therapy Salvage Surgery

Split Course Adaptive Radiation Therapy With Pembrolizumab With/Without Chemotherapy for Treating Stage IV Lung Cancer

PHASE1

This phase I/II trial tests the safety and efficacy of split-course adaptiv...

Status

Recruiting

Location

Vanderbilt University/Ingram Cancer Center

Start Date

2023-05-09

Trial ID

NCT05501665

Treatments Being Tested

Biospecimen Collection Carboplatin Computed Tomography Fludeoxyglucose F-18 Nab-paclitaxel Pembrolizumab Pemetrexed Positron Emission Tomography Radiation Therapy [18-F] (fluoropropyl)-L-glutamate (FSPG) PET scan Ipilimumab Nivolumab Cemiplimab Atezolizumab

Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy

PHASE2

This pilot study is configured as a non-inferiority comparison of Performan...

Status

Recruiting

Location

Wake Forest Baptist Comprehensive Cancer Center

Start Date

2020-07-01

Trial ID

NCT04253964

Treatments Being Tested

Pembrolizumab Atezolizumab Cemiplimab-Rwlc Carboplatin Paclitaxel Nab paclitaxel Pemetrexed Cisplatin Quality of Life Questionnaire, lung cancer-specific (QLQ-LC13)QLQ-C30 Global Health/Quality of Life Questionnaire COPD Assessment Test and modified Medical Research Council Dyspnea Patient Reported Outcomes PROMIS and FACT-G Questionnaires Sleep Disorder Assessments (ISI, Berlin Sleep Questionnaire)

Capecitabine/Oxaliplatin Chemotherapy and Cemiplimab With or Without Fianlimab or REGN7075 in Locally Advanced Rectal Cancer

PHASE2

The purpose of this study is to evaluate the safety and clinical activity o...

Status

Recruiting

Location

Johns Hopkins Sidney Kimmel Comprehensive Cancer Center

Start Date

2026-07-14

Trial ID

NCT07281768

Treatments Being Tested

Oxaliplatin Capecitabine Cemiplimab Fianlimab REGN7075

A Trial to Learn if the Combination of Fianlimab, Cemiplimab, and Chemotherapy is Safe and Works Better Than the Combination of Cemiplimab and Chemotherapy in Adult Patients With Non-Small Cell Lung Cancer That Can be Treated With Surgery

PHASE2

This study is researching an experimental drug called fianlimab (also calle...

Status

Active Not Recruiting

Location

Clermont Oncology Center

Start Date

2024-07-16

Trial ID

NCT06161441

Treatments Being Tested

Fianlimab Cemiplimab Pemetrexed Paclitaxel Carboplatin Cisplatin Placebo

Previous Next